These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 5015292)

  • 1. Methotrexate hepatotoxicity in psoriasis--comparison of different dose regimens.
    Dahl MG; Gregory MM; Scheuer PJ
    Br Med J; 1972 Mar; 1(5801):654-6. PubMed ID: 5015292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatotoxicity of methotrexate in the treatment of psoriasis.
    Palmer HM
    Practitioner; 1973 Sep; 211(263):324-8. PubMed ID: 4759241
    [No Abstract]   [Full Text] [Related]  

  • 3. Liver damage due to methotrexate in patients with psoriasis.
    Dahl MG; Gregory MM; Scheuer PJ
    Br Med J; 1971 Mar; 1(5750):625-30. PubMed ID: 5548839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatotoxicity of methotrexate in rheumatic diseases.
    Kevat S; Ahern M; Hall P
    Med Toxicol Adverse Drug Exp; 1988; 3(3):197-208. PubMed ID: 3041245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate induced liver disease in psoriasis.
    Millward-Sadler GH; Ryan TJ
    Br J Dermatol; 1974 Jun; 90(6):661-7. PubMed ID: 4853200
    [No Abstract]   [Full Text] [Related]  

  • 6. A prospective study of the effects of weekly oral methotrexate on liver biopsy.
    Warin AP; Landells JW; Levene GM; Baker H
    Br J Dermatol; 1975 Sep; 93(3):321-7. PubMed ID: 1103936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers for methotrexate-induced liver injury: urinary protein profiling of psoriasis patients.
    van Swelm RP; Laarakkers CM; Kooijmans-Otero M; de Jong EM; Masereeuw R; Russel FG
    Toxicol Lett; 2013 Aug; 221(3):219-24. PubMed ID: 23830989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatotoxicity of long-term methotrexate therapy for psoriasis.
    Tobias H; Auerbach R
    Arch Intern Med; 1973 Sep; 132(3):391-6. PubMed ID: 4783020
    [No Abstract]   [Full Text] [Related]  

  • 9. Liver biopsy in methotrexate-treated psoriatics-a re-evalution.
    Zachariae H; Grunnet E; Sogaard H
    Acta Derm Venereol; 1975; 55(4):291-6. PubMed ID: 52258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring liver function during methotrexate therapy for psoriasis: are routine biopsies really necessary?
    Thomas JA; Aithal GP
    Am J Clin Dermatol; 2005; 6(6):357-63. PubMed ID: 16343024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: are serial liver biopsies justified?
    Aithal GP; Haugk B; Das S; Card T; Burt AD; Record CO
    Aliment Pharmacol Ther; 2004 Feb; 19(4):391-9. PubMed ID: 14871278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis. An acceptable risk/benefit ratio.
    Lanse SB; Arnold GL; Gowans JD; Kaplan MM
    Dig Dis Sci; 1985 Feb; 30(2):104-9. PubMed ID: 3967557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate and liver function: a study of 13 psoriasis cases treated with different cumulative dosages.
    Carneiro SC; Cássia FF; Lamy F; Chagas VL; Ramos-e-Silva M
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):25-9. PubMed ID: 18181969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate hepatotoxicity in psoriatics: report of 104 patients from Nova Scotia, with analysis of risks from obesity, diabetes and alcohol consumption during long term follow-up.
    Malatjalian DA; Ross JB; Williams CN; Colwell SJ; Eastwood BJ
    Can J Gastroenterol; 1996 Oct; 10(6):369-75. PubMed ID: 9193771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate hepatotoxicity and concentrations of methotrexate and folate in erythrocytes--relation to liver fibrosis and cirrhosis.
    Zachariae H; Schrøder H; Foged E; Søgaard H
    Acta Derm Venereol; 1987; 67(4):336-40. PubMed ID: 2445154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient Elastography May Improve Detection of Liver Fibrosis in Psoriasis Patients Treated with Methotrexate.
    Talme T; Nikamo P; Rosenberg P; Ståhle M
    Acta Derm Venereol; 2017 Aug; 97(8):952-954. PubMed ID: 28422266
    [No Abstract]   [Full Text] [Related]  

  • 17. Liver injury associated with methotrexate therapy for psoriasis.
    Podurgiel BJ; McGill DB; Ludwig J; Taylor WF; Muller SA
    Mayo Clin Proc; 1973 Nov; 48(11):787-92. PubMed ID: 4758150
    [No Abstract]   [Full Text] [Related]  

  • 18. [Serum liver tests in patients treated with methotrexate. A retrospective analysis].
    Correa G H; Paredes S N
    Rev Med Chil; 2007 Aug; 135(8):1002-8. PubMed ID: 17989857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoriasis, methotrexate, and cirrhosis.
    JAMA; 1970 Apr; 212(2):314-5. PubMed ID: 5467236
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of transient elastography and FibroTest for monitoring hepatotoxicity in patients receiving methotrexate for psoriasis.
    Lynch M; Higgins E; McCormick PA; Kirby B; Nolan N; Rogers S; Lally A; Vellinga A; Omar H; Collins P
    JAMA Dermatol; 2014 Aug; 150(8):856-62. PubMed ID: 24964792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.